These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29021248)

  • 1. Live attenuated influenza vaccine for children.
    Drug Ther Bull; 2017 Oct; 55(10):114-117. PubMed ID: 29021248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal live attenuated seasonal influenza vaccine: does not challenge current practice.
    Prescrire Int; 2013 Sep; 22(141):201-4. PubMed ID: 24171209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinating high-risk children with the intranasal live-attenuated influenza vaccine: the Quebec experience.
    Quach C
    Paediatr Respir Rev; 2014 Dec; 15(4):340-7. PubMed ID: 25242731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial.
    Brooks WA; Zaman K; Lewis KD; Ortiz JR; Goswami D; Feser J; Sharmeen AT; Nahar K; Rahman M; Rahman MZ; Barin B; Yunus M; Fry AM; Bresee J; Azim T; Neuzil KM
    Lancet Glob Health; 2016 Dec; 4(12):e946-e954. PubMed ID: 27746226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live attenuated influenza vaccine in children.
    Ambrose CS; Walker RE; Connor EM
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds - a nationwide cohort study Finland, influenza season 2015/16.
    Nohynek H; Baum U; Syrjänen R; Ikonen N; Sundman J; Jokinen J
    Euro Surveill; 2016 Sep; 21(38):. PubMed ID: 27684447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study.
    Rose MA; Damm O; Greiner W; Knuf M; Wutzler P; Liese JG; Krüger H; Wahn U; Schaberg T; Schwehm M; Kochmann TF; Eichner M
    BMC Infect Dis; 2014 Jan; 14():40. PubMed ID: 24450996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in Belgium.
    Gerlier L; Lamotte M; Dos Santos Mendes S; Damm O; Schwehm M; Eichner M
    Paediatr Drugs; 2016 Aug; 18(4):303-18. PubMed ID: 27272706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany.
    Damm O; Eichner M; Rose MA; Knuf M; Wutzler P; Liese JG; Krüger H; Greiner W
    Eur J Health Econ; 2015 Jun; 16(5):471-88. PubMed ID: 24859492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live attenuated intranasal influenza vaccine.
    Esposito S; Montinaro V; Groppali E; Tenconi R; Semino M; Principi N
    Hum Vaccin Immunother; 2012 Jan; 8(1):76-80. PubMed ID: 22251995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.
    Baxter R; Eaton A; Hansen J; Aukes L; Caspard H; Ambrose CS
    Vaccine; 2017 Mar; 35(9):1254-1258. PubMed ID: 28162825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results.
    Pebody R; Warburton F; Ellis J; Andrews N; Potts A; Cottrell S; Johnston J; Reynolds A; Gunson R; Thompson C; Galiano M; Robertson C; Byford R; Gallagher N; Sinnathamby M; Yonova I; Pathirannehelage S; Donati M; Moore C; de Lusignan S; McMenamin J; Zambon M
    Euro Surveill; 2016 Sep; 21(38):. PubMed ID: 27684603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seasonal influenza vaccines.
    Fiore AE; Bridges CB; Cox NJ
    Curr Top Microbiol Immunol; 2009; 333():43-82. PubMed ID: 19768400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and risks of live attenuated influenza vaccine in young children.
    Oster G; Weycker D; Edelsberg J; Nichol KL; Klein JO; Belshe RB
    Am J Manag Care; 2010 Sep; 16(9):e235-44. PubMed ID: 21250400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing uptake of live attenuated influenza vaccine among children in the United States, 2008-2014.
    Rodgers L; Pabst LJ; Chaves SS
    Vaccine; 2015 Jan; 33(1):22-4. PubMed ID: 25448098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding Immunity in Children Vaccinated With Live Attenuated Influenza Vaccine.
    Shannon I; White CL; Nayak JL
    J Pediatric Infect Dis Soc; 2020 Mar; 9(Supplement_1):S10-S14. PubMed ID: 31848606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live attenuated influenza vaccine (Fluenz™): a guide to its use in the prevention of seasonal influenza in children in the EU.
    Scott LJ; Carter NJ; Curran MP
    Paediatr Drugs; 2012 Aug; 14(4):271-9. PubMed ID: 22702743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: a cluster randomized trial.
    Kwong JC; Pereira JA; Quach S; Pellizzari R; Dusome E; Russell ML; Hamid JS; Feinberg Y; Winter AL; Gubbay JB; Sirtonski B; Moher D; Sider D; Finkelstein M; Loeb M;
    Vaccine; 2015 Jan; 33(4):535-41. PubMed ID: 25488331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
    Piedra PA; Gaglani MJ; Riggs M; Herschler G; Fewlass C; Watts M; Kozinetz C; Hessel C; Glezen WP
    Pediatrics; 2005 Sep; 116(3):e397-407. PubMed ID: 16140685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.